ARTICLE | Company News
CareDx licenses Illumina's transplant diagnostics
May 11, 2018 6:14 PM UTC
CareDx Inc. (NASDAQ:CDNA) received exclusive, worldwide rights to next-generation sequencing bone marrow and solid organ transplantation diagnostics from Illumina Inc. (NASDAQ:ILMN)...